Joanna Le Noury
Overview
Explore the profile of Joanna Le Noury including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
188
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Healy D, Bahrick A, Bak M, Barbato A, Calabro R, Chubak B, et al.
Int J Risk Saf Med
. 2021 Nov;
33(1):65-76.
PMID: 34719438
Background: A set of enduring conditions have been reported in the literature involving persistent sexual dysfunction after discontinuation of serotonin reuptake inhibiting antidepressants, 5 alpha-reductase inhibitors and isotretinoin. Objective: To...
2.
Healy D, Le Noury J, Mangin D
Int J Risk Saf Med
. 2019 Aug;
30(3):167-178.
PMID: 31450514
Objective: A petition to the European Medicines Agency provided an opportunity to collect reports of a specific adverse event from patients and healthcare professionals, along with details of clinicians' attitudes...
3.
Healy D, Le Noury J, Jureidini J
Int J Risk Saf Med
. 2018 Jun;
30(1):1-7.
PMID: 29865094
The data supporting the use of "antidepressants" in children and adolescents is largely unavailable. Academic publications give a different picture as regards benefits and harms to publications from regulatory other...
4.
Healy D, Le Noury J, Mangin D
Int J Risk Saf Med
. 2018 May;
29(3-4):125-134.
PMID: 29733030
Objective: To investigate clinical reports of post-SSRI sexual dysfunction (PSSD), post-finasteride syndrome (PFS) and enduring sexual dysfunction following isotretinoin. Methods: Data from RxISK.org, a global adverse event reporting website, have...
5.
Le Noury J, Nardo J, Healy D, Jureidini J, Raven M, Tufanaru C, et al.
Int J Risk Saf Med
. 2016 Sep;
28(3):143-61.
PMID: 27662279
Objective: This is an analysis of the unpublished continuation phase of Study 329, the primary objective of which was to compare the efficacy and safety of paroxetine and imipramine with...
6.
Atigari O, Harris M, Le Noury J, Healy D
Hist Psychiatry
. 2016 Jan;
27(1):75-84.
PMID: 26769392
We compared admission rates and outcomes for bipolar disorder patients using the medical records of patients with a first hospital admission in 1875-1924 retrospectively diagnosed based on International Classification of...
7.
Le Noury J, Nardo J, Healy D, Jureidini J, Raven M, Tufanaru C, et al.
BMJ
. 2015 Oct;
351:h5412.
PMID: 26467813
No abstract available.
8.
Le Noury J, Nardo J, Healy D, Jureidini J, Raven M, Tufanaru C, et al.
BMJ
. 2015 Sep;
351:h4320.
PMID: 26376805
Objectives: To reanalyse SmithKline Beecham's Study 329 (published by Keller and colleagues in 2001), the primary objective of which was to compare the efficacy and safety of paroxetine and imipramine...
9.
Hogan C, Le Noury J, Healy D, Mangin D
Int J Risk Saf Med
. 2014 Jun;
26(2):109-16.
PMID: 24902508
Background: There have been reports for over a decade linking serotonin reuptake inhibitors, finasteride and isotretinoin with enduring sexual dysfunction after treatment stops. Objective: To explore the clinical pictures linked...
10.
Healy D, Howe G, Mangin D, Le Noury J
Int J Risk Saf Med
. 2014 Jun;
26(2):71-9.
PMID: 24902504
Adverse effects of treatment on cardiac QT intervals were first reported 50 years ago. A clear link to sudden death was established, but the problem remained relatively unknown. The issue...